Authors


Natalia Muhlemann

Latest:

Employing the Power of Bayesian Methods to Expedite Learning

Bayesian methods bring flexibility and speed to clinical trial design and analysis, and with increased access to the necessary computational power, are transforming today’s clinical research.



Nadir Ammour, MBA, DMD

Latest:

Innovations in Data Capture Transforming Trial Delivery

Advances in technology open door for improved EHR to EDC transfer process.


Aswin Chandrakantan

Latest:

Navigating Clinical Trial Recruitment in the Midst of COVID-19

Many companies during this time of social distancing have paused trial recruitment completely to focus on currently recruited patients, while others rethink their strategy to better accommodate the new digital-only reality.


Dan Ayala

Latest:

What’s Complicating Good Data Practices and Data Integrity?

Companies must be able to defend the fidelity and confidentiality of all records and data generated throughout a product’s entire lifecycle, starting with the earliest points in research.


Amandine Manon, PharmD

Latest:

FDA’s Project Optimus Guidance: Highlights and Tips for Success for Oncology Drug Developers

January 2023 guidance from FDA on dosages in oncology provides further context on expectations with Project Optimus.


Elisabeth Coart, PhD

Latest:

Integration of Biomarker Validation in Oncology Trials

Recent case study highlights the importance of applying statistical rigor throughout the development and validation processes of biomarkers.


Chris Ingram, Bsc (Hons)

Latest:

Evolution of the UK Legislative Framework for Clinical Trials

New proposals aim to create higher standards for trial regulation.


Michael G. Kelly, PhD

Latest:

Rare Disease Clinical Trials: Strategies Learned from Duchenne Muscular Dystrophy

Approaches sponsors, CROs, and investigators can take from the DMD experience.



Max Luccock

Latest:

Survey Results: GCP Quality and Risks in Decentralized Clinical Trials

Identifying and providing clarity on the GCP quality and risk concerns associated with DCT modalities.


Mac Winslow

Latest:

Considerations to Reach Underrepresented Groups

Regulatory compliance, collaboration, and effective use of technology among ways CROs can overcome challenges.


Brandy Morneau

Latest:

How to Navigate the Clinical Trial Complexities in a Post-COVID World

With various COVID-19 vaccine trials underway, a seamless clinical research process has never been more critical.


Matthew Satterthwaite

Latest:

How Sponsors Can Use Health Decision Science to Improve Clinical Trial Recruitment and Retention

Examining the behaviors of clinical trial stakeholders to better understand challenges in patient participation.


Robyn Owens

Latest:

Aligning Patient Burden with Planetary Burden

How making trial participation easier can reduce the impact on the environment.



David Li, MD, PhD

Latest:

Initial Design Considerations for Immuno-Oncology Trials

Perspectives and insights regarding regulatory considerations when planning and conducting immunotherapy studies.


Dan DeBonis

Latest:

How Digital Technology and Remote Assessment Strategies Can Aid Clinical Trial Research

While there's been hopeful news on treatments and vaccines, sponsors should plan to discuss necessary strategies and contingencies at the outset of new studies or re-opening of halted studies during the COVID-19 pandemic.


Jules Moritz

Latest:

When Trials Stumble, Mobile Research Nursing Lends a Helping Hand

With the assistance of mobile research nursing, in-home visits provide solid alternative to trial participants, especially during COVID-19.


Matt Latey

Latest:

Make Your Clinical Trial a Priority in a Busy Landscape

A more crowded space is presenting new challenges for stakeholders that must be addressed to improve efficiency.


Trinette Mitchell

Latest:

The Impact of Decentralized and Hybrid Trials on Sponsor and CRO Collaborations

Tufts CSDD study in collaboration with ten biopharmaceutical organizations and CROs examines sponsor/CRO relationships.


Alexandra Kalpadakis-Smith, PhD

Latest:

Properly Training Physicians in Dermatology Trials

Poor representation of dark skin tones in textbooks emphasizes need for change.


Kate Godwin-Smith

Latest:

Better Patient Engagement Begins With Electronic Informed Consent

While eConsent has become more widely adopted since COVID-19, work still needs to be done in improving patients’ understanding.


Evidera

Latest:

Addressing Challenges With Intelligent Point-of-Care Device Deployment

Key challenges and strategies to consider when developing devices intended for home-use or deployment in a clinical research setting.


Natalia Husby

Latest:

Changing the Face—and Faces—of Clinical Research

The six steps to designing a successful diversity action plan for a clinical trial protocol.


Jill Platko

Latest:

The Importance of Simple Clinical Trial Diaries

Sponsors can simplify diaries by taking a closer look at the three common sources of complexity.


Libbi Rickenbacher

Latest:

Increased Digitization in Clinical Trials: Expectations for the Year Ahead

Top predictions for the major trends that will shape clinical trial design in 2022.


Pierre Etienne

Latest:

Just How ‘Real’ is Real-World Data?

Addressing sources of tension on differentiating types of data.


Brian O’Dwyer

Latest:

Self-collection of Blood Specimens in Clinical Trials

Operational and patient burden considerations for self-collection of blood specimens in clinical trials


Steve Sibley

Latest:

Simultaneous New Drug Submissions: Is it Possible?

A roadmap to avoiding the common pitfalls of concurrent FDA-EMA filings.

© 2024 MJH Life Sciences

All rights reserved.